Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Ann Rheum Dis. 2017 Oct 27;76(12):1955–1964. doi: 10.1136/annrheumdis-2017-211468

Table 4.

Performance of the EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) and existing classification and diagnostic criteria for IIM

PERFORMANCE (%) The EULAR/ACR classification criteria for IIM*
Bohan and Peter [7, 8] Tanimoto et al. [10] Targoff et al. [11] Dalakas and Hohlfeld [14] ENMC Hoogendijk et al. [15]
Without muscle biopsy With muscle biopsy

Mean (95% CI)
Sensitivity 87
(84–90)
93
(89–95)
98
(96–99)
96
(94–97)
93
(90–95)
6
(5–8)
52
(48–55)
Specificity 82
(77–87)
88
(83–93)
55
(50–61)
31
(25–37)
89
(84–92)
99
(98–100)
97
(95–98)

Mean
Positive predictive value 90 94 85 80 95 92 96
Negative predictive value 79 85 90 73 85 43 57
Correctly classified 86 91 86 79 91 45 70

CORRECT CLASSIFICATION OF IIM PER SUBGROUP (%)

Amyopathic dermatomyositis 94 60 25 14 0 0 0
Dermatomyositis 96 98 100 96 99 7 83
Hypomyopathic dermatomyositis 83 100 80 40 67 0 20
Immune-mediated necrotizing myopathy 100 100 100 100 100 0 10
Inclusion body myositis 58 94 97 97 91 1 1
Juvenile dermatomyositis 97 96 100 96 98 5 86
Polymyositis 79 86 95 100 85 11 9
*

Cutoff for probability: 55%

Definite and probable polymyositis and dermatomyositis

Classification as idiopathic inflammatory myopathy per subgroup out of total number of cases per subgroup, expressed as mean

IIM, idiopathic inflammatory myopathies; ENMC, European Neuromuscular Centre; CI, confidence interval